269 related articles for article (PubMed ID: 30039492)
41. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
[TBL] [Abstract][Full Text] [Related]
42. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
[TBL] [Abstract][Full Text] [Related]
43. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
Li Q; Hou J; Hu Z; Gu B; Shi Y
Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
[TBL] [Abstract][Full Text] [Related]
44. The bioinformatics analysis of RIOX2 gene in lung adenocarcinoma and squamous cell carcinoma.
Sun B; Zhao H
PLoS One; 2021; 16(12):e0259447. PubMed ID: 34855761
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma.
Qu Y; Cheng B; Shao N; Jia Y; Song Q; Tan B; Wang J
Aging (Albany NY); 2020 Mar; 12(6):4757-4777. PubMed ID: 32209727
[TBL] [Abstract][Full Text] [Related]
46. Analysis of gene expression profiles of lung cancer subtypes with machine learning algorithms.
Yuan F; Lu L; Zou Q
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165822. PubMed ID: 32360590
[TBL] [Abstract][Full Text] [Related]
47. An integrative investigation on significant mutations and their down-stream pathways in lung squamous cell carcinoma reveals CUL3/KEAP1/NRF2 relevant subtypes.
Liu Z; Deng M; Wu L; Zhang S
Mol Med; 2020 May; 26(1):48. PubMed ID: 32434476
[TBL] [Abstract][Full Text] [Related]
48. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
[TBL] [Abstract][Full Text] [Related]
49. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
50. Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.
Shang J; Wang Z; Chen W; Yang Z; Zheng L; Wang S; Li S
J Cell Physiol; 2019 Aug; 234(8):13735-13746. PubMed ID: 30623445
[TBL] [Abstract][Full Text] [Related]
51. High
Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
[TBL] [Abstract][Full Text] [Related]
52. The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing.
Wang C; Yu Q; Song T; Wang Z; Song L; Yang Y; Shao J; Li J; Ni Y; Chao N; Zhang L; Li W
Signal Transduct Target Ther; 2022 Aug; 7(1):289. PubMed ID: 36008393
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA dysregulational synergistic network: discovering microRNA dysregulatory modules across subtypes in non-small cell lung cancers.
Tran N; Abhyankar V; Nguyen K; Weidanz J; Gao J
BMC Bioinformatics; 2018 Dec; 19(Suppl 20):504. PubMed ID: 30577741
[TBL] [Abstract][Full Text] [Related]
54. Expression Pattern and Prognostic Analysis of Branched-Chain Amino Acid Catabolism-Related Genes in Non-Small Cell Lung Cancer.
Yao X; Deng Y; Zhou J; Jiang L; Song Y
Front Biosci (Landmark Ed); 2023 Jun; 28(6):107. PubMed ID: 37395022
[TBL] [Abstract][Full Text] [Related]
55. ΔNp63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer.
Napoli M; Wu SJ; Gore BL; Abbas HA; Lee K; Checker R; Dhar S; Rajapakshe K; Tan AC; Lee MG; Coarfa C; Flores ER
Nat Commun; 2022 Feb; 13(1):614. PubMed ID: 35105868
[TBL] [Abstract][Full Text] [Related]
56. Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma.
Uzelac M; Li Y; Chakladar J; Li WT; Ongkeko WM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232866
[TBL] [Abstract][Full Text] [Related]
57. Elevated Expression of
Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
[TBL] [Abstract][Full Text] [Related]
58. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
Liu X; Chen L; Zhang T
Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
[TBL] [Abstract][Full Text] [Related]
59. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
[TBL] [Abstract][Full Text] [Related]
60. The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases.
Liang Y; Lei Y; Du M; Liang M; Liu Z; Li X; Gao Y
J Cell Mol Med; 2021 Jul; 25(14):7039-7051. PubMed ID: 34117717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
